Spectrum Science, a founder-led life sciences communications business, is exploring strategic alternatives in response to inbound interest, sources tell Axios.
Why it matters: Many scale assets in this space have come to market and transacted over the last 18 months. Spectrum, while smaller, is fast-growing — presenting an opportunity for PE groups that have gotten educated on med comms (and chased other assets) but have yet to score an entry point.
